Sec Form 13G Filing - FROST PHILLIP MD filing for Douglas Elliman Inc. (DOUG) - 2025-02-11

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Note to row 6, 8, 9 and 11: Includes 7,641,642 shares of Common Stock of the Issuer held by FGIT (as defined herein) and 8,976 shares of Common Stock held by Patricia Frost (as defined herein) as of the date hereof, as to which shares Dr. Frost disclaims beneficial ownership.Note to row 11: The calculation of all percentages set forth herein is based on 89,166,991 shares of Common Stock outstanding as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ending September 30, 2024 filed with the Securities and Exchange Commission (the "SEC") on November 12, 2024.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note to row 11: The calculation of all percentages set forth herein is based on 89,166,991 shares of Common Stock outstanding as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ending September 30, 2024 filed with the SEC on November 12, 2024.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note to row 9 and 11: These shares are owned by Patricia Frost, the spouse of Dr. Frost. Dr. Frost disclaims beneficial ownership of these shares.Note to row 11: Patricia Frost holds less than 0.1%. The calculation of all percentages set forth herein is based on 89,166,991 shares of Common Stock outstanding as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ending September 30, 2024 filed with the SEC on November 12, 2024.


SCHEDULE 13G


 
Phillip Frost, M.D.
 
Signature:/s/ Phillip Frost, M.D.
Name/Title:Phillip Frost, M.D./Individually
Date:02/11/2025
 
Frost Gamma Investments Trust
 
Signature:/s/ Phillip Frost, M.D.
Name/Title:Phillip Frost, M.D./Trustee
Date:02/11/2025
 
Patricia Frost
 
Signature:/s/ Patricia Frost
Name/Title:Patricia Frost/Individually
Date:02/11/2025
Exhibit Information

99.1 Joint Filing Agreement

primary_doc.xml